A patient with plaque-stage mycosis fungoides has successfully been treated with long-term administration of IFN-γ and has been in complete remission for more than 6 years

This publication has 13 references indexed in Scilit:

• Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
  The Journal of Experimental Medicine, 1993
• The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sezary T cells
  Archives of Dermatology, 1993
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
  The Journal of Experimental Medicine, 1993
• Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation
  Archives of Dermatology, 1993
• Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells
  Journal of Investigative Dermatology, 1992
• Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.
  The Journal of Experimental Medicine, 1989
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
  The Journal of Experimental Medicine, 1989
• Successful treatment of plaque stage mycosis fungoides with recombinant interferon-.GAMMA. (SUN 4800) alone.
  The Nishinihon Journal of Dermatology, 1989
• Association of Vesiculobullous Eruptions with Mycosis fungoides
  Dermatology, 1987
• Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results
  Archives of Dermatology, 1977